Livermore, CA, United States of America

Kelly Porter Williams

This inventor holds 1 USPTO granted patent. Top assignee: National Technology & Engineering Solutions of Sandia, LLC. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kelly Porter Williams. Retrieved from https://idiyas.com/inventor/kelly-porter-williams

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kelly Porter Williams: Innovator in Therapeutic Phages

Introduction

Kelly Porter Williams is a prominent inventor based in Livermore, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic phages. Her innovative work focuses on engineered viruses and their applications in targeting pathogenic bacteria.

Latest Patents

Kelly holds a patent for "Therapeutic phages and methods thereof." This invention relates to engineered viruses, specifically engineered phages, and phage cocktails. It also includes methods for producing and identifying viruses that can effectively target harmful bacteria.

Career Highlights

Kelly is currently employed at National Technology & Engineering Solutions of Sandia, LLC. Her role at this esteemed organization allows her to further her research and development efforts in the field of therapeutic applications.

Collaborations

Some of her notable coworkers include Steven Branda and Raga Krishnakumar. Their collaboration enhances the innovative environment in which Kelly works, fostering advancements in biotechnology.

Conclusion

Kelly Porter Williams is a trailblazer in the field of therapeutic phages, with a focus on engineered viruses for medical applications. Her contributions are paving the way for new treatments targeting bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…